ArticleBlood cancer journal2026

Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.

Joshua N Gustine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.